HMA makes public rejected EU drug applications
This article was originally published in SRA
Executive Summary
The EU Heads of Medicines Agencies has published a template for issuing public assessment reports on drug applications that are refused marketing authorization under the EU's mutual recognition and decentralized procedures1.